Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Sufentanil and midazolam dosing and pharmacogenetic factors in pediatric analgosedation and withdrawal syndrome.

Physiological research - 21 Dec 2016

Hronová K, Pokorná P, Posch L, Slanař O

Abstract excerpt

Our aim was to describe the effect of dosing and genetic factors on sufentanil- and midazolam-induced analgosedation and withdrawal syndrome (WS) in pediatric population. Analgosedation and withdrawal syndrome development were monitored using COMFORT-neo/-B scores and SOS score. Length of therapy, dosing of sufentanil and midazolam were recorded. Genotypes of selected candidate polymorphisms in CYP3A5, COMT,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Child
Share to Dose-Response Relationship, Drug
Share to Infant

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Infant, Newborn

Share to Midazolam

Share to Pediatrics

Share to Pharmacogenetics

Share to Substance Withdrawal Syndrome

Source

Identifiers

PMID: 28006928
DOI: 10.33549/physiolres.933519

Genes

ABCB1
COMT
OPRM1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Sufentanil and midazolam dosing and pharmacogenetic factors in pediatric analgosedation and withdrawal syndrome.PMID 28006928Read ↗

A short investigation: the demographic data of pharmacogenomics testing results for asian pediatric perioperative drugsSemantic proximity Read ↗

[Impact of genetic factors on severity of side effects of opioids in patients after major surgical interventions].Semantic proximity Read ↗

The pharmacogenetics of medications used in general anesthesia.Semantic proximity Read ↗

Neonatal medications.Semantic proximity Read ↗

Codeine and opioid metabolism: implications and alternatives for pediatric pain management.Semantic proximity Read ↗

Can pharmacogenetics inform morphine dosing in the neonatal intensive care unit? A retrospective evaluation.Semantic proximity Read ↗

Genetics of pain perception, COMT and postoperative pain management in children.Semantic proximity Read ↗

Low-concentration, low-dose lidocaine in ultrasound-guided sacral anesthesia reduces postoperative agitation and delirium in children undergoing hidden penis and hypospadias surgery: A prospective, randomized, controlled studySemantic proximity Read ↗

Low-concentration, low-dose lidocaine in ultrasound-guided sacral anesthesia reduces postoperative agitation and delirium in children undergoing hidden penis and hypospadias surgery: A prospective, randomized, controlled studySemantic proximity Read ↗

Is ethnicity associated with morphine's side effects in children? Morphine pharmacokinetics, analgesic response, and side effects in children having tonsillectomy.Semantic proximity Read ↗

[Codeine--Restrictions on use for children and teenagers].Semantic proximity Read ↗

Pharmacogenetics and anesthetic drugs.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.